|Articles|May 1, 2001

Artherosclerosis: Achieving Optimal Outcomes in Statin Therapy
Volume 7
Issue 5 Suppl

Threshold Level or Not for Low-Density Lipoprotein Cholesterol

Author(s)Philip J. Barter, MD, PhD, FRACP, Frank M. Sacks, MD

Download PDF: Threshold Level or Not for Low-Density Lipoprotein Cholesterol

Articles in this issue

over 25 years ago

Article

Participating Faculty

over 25 years ago

Article

Introduction

over 25 years ago

Article

Should All Patients with Cardiovascular Disease Receive Statin Therapy?

over 25 years ago

Article

Statins--Differences and Similarities

over 25 years ago

Article

What Do the Statin Trials Tell Us?

over 25 years ago

Article

Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Management

over 25 years ago

Article

New Therapies on the Horizon

over 25 years ago

Article

A New Statin: A New Standard

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Pregnant woman | Image credit: pressmaster - stock.adobe.com

Early Signs of Success for Missouri’s New Notification of Pregnancy

ByAbigail R. Barker, PhD,Nadim Kanafani, MD,Kelley M. Peters, MS, RN, BSN,Rashmi Srivastava, MD, BS

September 15th 2026

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Threshold Level or Not for Low-Density Lipoprotein Cholesterol

Articles in this issue

Related Content

Early Signs of Success for Missouri’s New Notification of Pregnancy

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Trending on AJMC

FDA Clears First Alzheimer Blood Test for Adults as Young as 40

MFN Drug Agreements Could Raise Prices Worldwide

Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD

5 Things to Know About the 2026 ESC Heart Failure Guidelines

Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD